Made In India Surgical Robot Completes 100 Surgeries Within Six Months
Robotic-assisted surgeries have gained significant ground in the last few years and patients are increasingly embracing them for the high clinical outcomes, low risk and faster recoveries. However, robotic surgeries have been construed for only the elite class because of the exorbitant costs attached. With SSI Mantra, the company says the game is about to change, the company said in a statement.
Within six months of its commercial launch, the surgical robot has successfully completed 100 surgeries validating the supremacy of the home-grown robot and its ability to perform complex surgeries with flawless precision, the company's statement added.
Dr Sudhir Srivastava, Founder, Chairman and CEO, SS Innovations says, “Achieving 100 successful surgeries by SSI MANTRA is satisfying both emotionally and professionally for me as it marks a significant milestone in India’s quest to redefine the surgical landscape of the country. SSI MANTRA costing just one-third of its global competitors has significantly brought down the cost of surgeries making it much more affordable.
He further said that India can now look forward to high-end medical care and surgeries without having to worry much about the cost factor. It is a reinforcement of our belief in the system and we are greatly thankful to the medical fraternity for putting confidence in our system and our abilities to provide a surgical option which is at par with its global counterparts”.
SSI Mantra was first commercially installed at the Rajiv Gandhi Cancer Institute, New Delhi in July 2022. Since its maiden installation at RGCI, the SSI Mantra system has gained acceptance from many quarters of the country and has been installed in Sanjeevani CBCC USA Cancer Hospital, Raipur; Continental Hospital, Hyderabad and Hindustan Hospital, Coimbatore.
